Cosmetic Treatments and Strategies for the Upper Face

Facial Plastic Surgery Clinics of North America

Volumn 15, Issue 1, 2007, Pages 31-39

  Frankel, Andrew S ^a,b   Markarian, Alex ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Lasky Clinic   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

CRANIOFACIAL MORPHOLOGY; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG USE; ESTHETIC SURGERY; ESTHETICS; FACE; HUMAN; PATIENT ASSESSMENT; REVIEW;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; FACIAL MUSCLES; HUMANS; INJECTIONS, SUBCUTANEOUS; NEUROMUSCULAR AGENTS; SKIN AGING;

EID: 33847054692     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2006.11.004     Document Type: Review

References (20)

1. Carruthers J., and Carruthers A. Treatment of glabellar frown lines with C. Botulinum exotoxin. J Dermatol Surg Oncol 18 (1992) 17-21
2. Carruthers A., Carruthers J., and Cohen J. A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead lines. Dermatol Surg 29 5 (2003) 461-467
3. Dermatol Surg 24 (1998) 11 [special issue]
4. Dermatol Surg 29 (2003) 5 [special issue]
5. Facial Plast Surg Clin N Am 11 (2003) 4
6. Plast Reconstr Surg 112 (2003) 5 [supplement]
7. Plast Reconstr Surg 114 (2004) 1S-22S [supplement]
8. Simpson L.L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33 (1981) 155-188
9. Steel D.H., Hoh H.B., Harrad R.A., et al. Botulinum toxin for the temporary treatment of involutional lower lid entropion: a clinical and morphological study. Eye 11 (1997) 472-475
10. Glassner H.G., and Sherris D.A. Chemoimmobilization: improving predictability in the treatment of facial scars. Plast Reconstr Surg 112 5 (2003) 1464-1466
11. Carruthers J., and Carruthers A. The adjunctive usage of botulinum toxin. Dermatol Surg 24 (1998) 1244-1247
12. Wang Y.C., Burr D.H., Korthals G.J., et al. Acute toxicity of aminoglycoside antibiotics as an aid in detecting botulism. Appl Environ Microbiol 48 (1984) 951-955
13. Botox. [Package Insert] (2006), Allergan, Inc., Irvine CA
14. Klein A.W. Dilution and storage of botulinum toxin. Dermatol Surg 24 (1998) 1179-1180
15. de Almedia A.R.T., Kadunc B.V., Chiacchio N.D., et al. Foam during reconstitution does not affect the potency of botulinum toxin type A. Dermatol Surg 29 5 (2003) 530-531
16. Hexsal D.M., de Almeida A.T., Rutowitsch M., et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg 29 5 (2003) 523-529
17. Carruthers J.A., Lowe N.J., Menter M.A., et al. A multicenter double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermato 46 (2002) 840-849
18. Frankel A.S., and Kamer F.M. Chemical brow lift. Arch Otolaryngol Head Neck Surg 124 (1998) 321-323
19. Ahn M.S., Catten M., and Maas C.S. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg 112 5 (2003) 98S-103S
20. Yamauchi P.S., Lask G., and Lowe N.J. Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing. J Cosmet Laser Ther 6 3 (2004) 145-148